NVCT · Company research
Nuvectis Pharma, Inc. (NVCT): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Understanding Momentum Shifts in (NVCT) - Stock Traders Daily | Understanding Momentum Shifts in (NVCT) Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 17, 2026 | neutral | 0 | 0.6 |
| Nuvectis Pharma Inc (NVCT-Q) Stock Price and News - The Globe and Mail | Nuvectis Pharma Inc (NVCT-Q) Stock Price and News The Globe and Mail | View source ↗ | The Globe and Mail | Oct 10, 2026 | neutral | 0 | 0.6 |
| Nuvectis Pharma (NVCT) Short Interest & Short Float | Updated Oct 2026 - MarketBeat | Nuvectis Pharma (NVCT) Short Interest & Short Float | Updated Oct 2026 MarketBeat | View source ↗ | MarketBeat | Oct 9, 2026 | neutral | 0 | 0.6 |
| (NVCT) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily | (NVCT) Movement Within Algorithmic Entry Frameworks Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 7, 2026 | neutral | 0 | 0.6 |
| NVCT: Nuvectis Pharma Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits | NVCT: Nuvectis Pharma Inc Latest Stock Price, Analysis, News and Trading Ideas Stocktwits | View source ↗ | Stocktwits | Oct 2, 2026 | neutral | 0 | 0.6 |
| NVCT Stock Price, Quote & Chart - ChartMill | NVCT Stock Price, Quote & Chart ChartMill | View source ↗ | ChartMill | Sep 25, 2026 | neutral | 0 | 0.6 |
| A brain tumor drug gets China’s breakthrough designation. Nuvectis is advancing NXP200 toward a U.S. filing in Q4. - Stock Titan | A brain tumor drug gets China’s breakthrough designation. Nuvectis is advancing NXP200 toward a U.S. filing in Q4. Stock Titan | View source ↗ | Stock Titan | Sep 24, 2026 | neutral | 0 | 0.6 |
| Nuvectis Pharma: Haisco Licensing Deal Revitalizes Biotech - But No Rush To Invest Today - Seeking Alpha | Nuvectis Pharma: Haisco Licensing Deal Revitalizes Biotech - But No Rush To Invest Today Seeking Alpha | View source ↗ | Seeking Alpha | Sep 18, 2026 | neutral | 0 | 0.6 |
| Nuvectis Pharma (NASDAQ: NVCT) sets at-the-market share sales via Jefferies - Stock Titan | Nuvectis Pharma (NASDAQ: NVCT) sets at-the-market share sales via Jefferies Stock Titan | View source ↗ | Stock Titan | Aug 21, 2026 | neutral | 0 | 0.6 |
| We're Not Very Worried About Nuvectis Pharma's (NASDAQ:NVCT) Cash Burn Rate - Simply Wall Street | We're Not Very Worried About Nuvectis Pharma's (NASDAQ:NVCT) Cash Burn Rate Simply Wall Street | View source ↗ | Simply Wall Street | Aug 20, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: 10% owner at $NVCT Buys 50,000 Shares | NVCT Stock News - Quiver Quantitative | Insider Purchase: 10% owner at $NVCT Buys 50,000 Shares | NVCT Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 1, 2026 | neutral | 0 | 0.6 |
| What Makes Nuvectis Pharma, Inc. (NVCT) a Strong Momentum Stock: Buy Now? - Yahoo Finance | What Makes Nuvectis Pharma, Inc. (NVCT) a Strong Momentum Stock: Buy Now? Yahoo Finance | View source ↗ | Yahoo Finance | Jul 1, 2026 | neutral | 0 | 0.6 |
| Nuvectis Pharma shares slide after pricing $100 million discounted stock offering (NVCT) - Yahoo Finance | Nuvectis Pharma shares slide after pricing $100 million discounted stock offering (NVCT) Yahoo Finance | View source ↗ | Yahoo Finance | Jun 30, 2026 | neutral | 0 | 0.6 |
| NVCT Forecast — Price Target — Prediction for 2027 - TradingView | NVCT Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Market Movers | Winners: SKYQ, NVCT, ABSI | Losers: ATLN, HTZ, CGTX - Trefis | Market Movers | Winners: SKYQ, NVCT, ABSI | Losers: ATLN, HTZ, CGTX Trefis | View source ↗ | Trefis | Jun 25, 2026 | neutral | 0 | 0.6 |
| Nuvectis Pharma Jumps 20% To 52-Week High — Here's Why NVCT Stock Is Trending - Benzinga | Nuvectis Pharma Jumps 20% To 52-Week High — Here's Why NVCT Stock Is Trending Benzinga | View source ↗ | Benzinga | Jun 23, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.